Group A Streptococcal Infections
文献摘要
Group A Streptococcus (GAS), or Streptococcus pyogenes, is a gram-positive bacterium that is uniquely adapted to humans and found almost exclusively in the human body. GAS is responsible for a wide range of infections, most commonly involving the upper respiratory tract and skin. In addition, GAS can cause severe invasive infections, including streptococcal toxic shock syndrome (STSS), necrotizing fasciitis, bacteremia, pneumonia, and meningitis. GAS infections are common. Hundreds of millions of noninvasive infections, including pharyngitis, scarlet fever, and impetigo, occur globally each year. Although invasive infections such as STSS and necrotizing fasciitis occur much less commonly than noninvasive infections, hundreds of thousands of invasive GAS (iGAS) infections occur globally every year. GAS can also lead to post-infectious immune-mediated sequelae, including acute rheumatic fever (ARF), post-streptococcal glomerulonephritis (PSGN), and complications from immune-mediated processes, such as rheumatic heart disease (RHD). GAS is the leading bacterial cause of acute pharyngitis, accounting for 5 to 15 percent of ambulatory care visits for acute pharyngitis in adults and 20 to 30 percent in children. Timely diagnosis and treatment are essential to prevent ARF and other post-infectious sequelae. Established criteria, diagnostic methods, and guidelines for managing GAS pharyngitis aim to ensure timely diagnosis and reduce the risk of complications, such as peritonsillar abscess, iGAS infections, immune-mediated sequelae, and GAS transmission. Despite the availability of guidelines for diagnosing GAS pharyngitis, antibiotics are often overprescribed, leading to unnecessary exposure and contributing to antibiotic resistance. Antibiotic resistance has been reported with various antibiotics, including macrolides (such as erythromycin and azithromycin) and lincosamides (including clindamycin). Overprescription is driven by several factors, including poor adherence to guidelines, challenges in accurately diagnosing GAS pharyngitis, misdiagnosing GAS carriage as active infection, and pressure from patients and clinicians to prescribe antibiotics. Clinicians must exercise caution and prescribe antibiotics only when necessary to minimize antibiotic pressure and reduce the risk of resistance development.